Rong Chen
Technik-/Wissenschafts-/F&E-Leiter bei JHL BIOTECH, INC.
Aktive Positionen von Rong Chen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JHL BIOTECH, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 | - |
Karriereverlauf von Rong Chen
Ehemalige bekannte Positionen von Rong Chen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Technik-/Wissenschafts-/F&E-Leiter | 04.03.2015 | - |
Ausbildung von Rong Chen
| Shandong Medical University | Undergraduate Degree |
| University of Adelaide | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 2 |
| China | 2 |
| Australien | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
